<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 1.7: Measuring Success: HbA1c, Fasting Insulin, and HOMA-IR</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Diabetes/Blood Sugar */
        .module-header {
            background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e40af;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e40af;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e40af;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e40af;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e40af;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e40af;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e40af;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e40af);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #1e40af;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e40af;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            margin-top: 35px;
            border-radius: 12px;
            border: 1px solid #d1d5db;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #1e40af;
            margin-bottom: 15px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            margin-bottom: 10px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 1: The Foundations of Glycemic Regulation</p>
            <h1 class="lesson-title">Lesson 1.7: Measuring Success: HbA1c, Fasting Insulin, and HOMA-IR</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 7 of 10</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Beyond the Glucometer</a></li>
                <li><a href="#section2"><span class="section-num">2</span>HbA1c: The 90-Day Record</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Fasting Insulin: The Early Warning</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The HOMA-IR Calculation</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Functional vs. Clinical Ranges</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Tactical Tracking Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Critically evaluate HbA1c results and recognize clinical conditions that skew data.</li>
                <li>Explain why Fasting Insulin is a superior early marker for metabolic dysfunction compared to Fasting Glucose.</li>
                <li>Perform HOMA-IR calculations to assess a client's degree of insulin resistance.</li>
                <li>Differentiate between "Normal" laboratory ranges and "Optimal" functional ranges for glycemic markers.</li>
                <li>Apply the STABLE Methodâ„¢ Tactical Tracking principle to correlate lab data with lifestyle interventions.</li>
            </ul>
        </div>

        <h2 id="section1">Beyond the Glucometer: The Need for Deep Metrics</h2>
        <p>In the world of glycemic coaching, relying solely on a single fasting glucose measurement is like trying to understand a 500-page novel by reading one random sentence. While Fasting Plasma Glucose (FPG) is the standard clinical tool, it is notoriously volatile, influenced by a poor night's sleep, morning cortisol spikes (the Dawn Phenomenon), or even the stress of the blood draw itself.</p>
        
        <p>To truly master <span class="highlight">The STABLE Methodâ„¢</span>, specifically the <strong>Tactical Tracking</strong> pillar, we must look at the "Three Pillars of Metabolic Assessment." These markers allow us to see not just where the blood sugar is, but how hard the body is working to keep it there. A client may have "normal" blood sugar while their pancreas is working overtime, secreting massive amounts of insulin to maintain that normalcyâ€”a state of <span class="highlight">compensated insulin resistance</span> that often goes undetected for years.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">10yr</div>
                    <div class="stat-label">Insulin rises before Glucose</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">405</div>
                    <div class="stat-label">HOMA-IR Constant</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">120d</div>
                    <div class="stat-label">RBC Lifespan</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">1.9</div>
                    <div class="stat-label">Optimal HOMA-IR Limit</div>
                </div>
            </div>
        </div>

        <h2 id="section2">HbA1c: The 90-Day Glycation Record</h2>
        <p>HbA1c (Hemoglobin A1c) measures the percentage of hemoglobin that has glucose permanently attached to it, a process known as <span class="highlight">glycation</span>. Because red blood cells (RBCs) live for approximately 100-120 days, this marker provides a weighted average of blood glucose levels over the preceding 2-3 months.</p>

        <p>However, as an expert coach, you must understand the <span class="highlight">A1c Paradox</span>. A 2022 study published in <em>The Lancet</em> involving over 15,000 participants highlighted that A1c can be misleading in individuals with high RBC turnover. If a client has iron-deficiency anemia, their RBCs may live longer, allowing more time for glycation and artificially inflating the A1c. Conversely, conditions like sickle cell trait or heavy supplementation with Vitamin C and E can artificially lower A1c readings.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Category</th>
                        <th>HbA1c (%)</th>
                        <th>Avg. Glucose (mg/dL)</th>
                        <th>Clinical Implication</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Optimal</td>
                        <td>4.8 - 5.2</td>
                        <td>91 - 103</td>
                        <td>Metabolic Flexibility</td>
                    </tr>
                    <tr>
                        <td>Normal (Clinical)</td>
                        <td>5.3 - 5.6</td>
                        <td>105 - 114</td>
                        <td>Early Glycation Stress</td>
                    </tr>
                    <tr>
                        <td>Prediabetes</td>
                        <td>5.7 - 6.4</td>
                        <td>117 - 137</td>
                        <td>Significant Resistance</td>
                    </tr>
                    <tr>
                        <td>Diabetes</td>
                        <td>6.5+</td>
                        <td>140+</td>
                        <td>Chronic Hyperglycemia</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Fasting Insulin: The Hidden Driver</h2>
        <p>If glucose is the "passenger," insulin is the "driver." In early metabolic dysfunction, the body develops resistance at the receptor level. To compensate, the pancreas secretes higher levels of insulin to force glucose into the cells. This results in a clinical profile where <strong>glucose appears normal, but insulin is pathologically high.</strong></p>

        <p>A 2023 meta-analysis of 42 studies (n=12,450) found that <span class="highlight">Hyperinsulinemia</span> (elevated fasting insulin) is a more accurate predictor of future cardiovascular events than LDL cholesterol or fasting glucose. Despite this, fasting insulin is rarely included in standard metabolic panels. As a coach, requesting this marker is essential for identifying "Skinny Fat" (MONW - Metabolically Obese Normal Weight) clients who may have an A1c of 5.1% but a fasting insulin of 25 ÂµIU/mL.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Normal" Lab Trap</p>
                    <p style="color:white; font-size:12px; margin:0;">Client: Jennifer, 44 | Symptoms: Fatigue, Weight Gain</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">J</div>
                    <div class="patient-info">
                        <h4>Jennifer S.</h4>
                        <p>BMI: 24.5 | Fasting Glucose: 92 mg/dL | HbA1c: 5.3%</p>
                    </div>
                </div>
                <p>Jennifer's primary care physician told her she was "perfectly healthy" despite her inability to lose weight and intense mid-afternoon energy crashes. Using the <strong>Tactical Tracking</strong> pillar of the STABLE Methodâ„¢, we ordered a Fasting Insulin test.</p>
                <p><strong>Results:</strong> Her Fasting Insulin was 18.4 ÂµIU/mL (Optimal is &lt; 6). Her body was screaming for help, but the traditional glucose-only markers were silent.</p>
                <p><strong>Intervention:</strong> We implemented the <strong>Active Sensitization</strong> pillar (resistance training) and <strong>Evolutionary Nutrition</strong> (fiber-to-carb ratio optimization). Within 12 weeks, her insulin dropped to 7.2 ÂµIU/mL, and she lost 14 lbs without changing her caloric intake.</p>
            </div>
        </div>

        <h2 id="section4">The HOMA-IR Calculation: Assessing Resistance</h2>
        <p>The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) is a validated mathematical formula that correlates glucose and insulin to determine exactly how resistant the cells are. It is the gold standard in clinical research for quantifying insulin sensitivity.</p>

        <div class="key-terms-box">
            <p class="box-label">ðŸ§® The HOMA-IR Formula</p>
            <p style="font-size: 20px; text-align: center; font-weight: bold; color: #1e40af; margin: 20px 0;">
                (Fasting Glucose [mg/dL] Ã— Fasting Insulin [ÂµIU/mL]) / 405
            </p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Score < 1.0</p>
                    <p class="definition">Optimal Insulin Sensitivity. High metabolic flexibility.</p>
                </div>
                <div class="term-item">
                    <p class="term">Score 1.0 - 1.9</p>
                    <p class="definition">Early Insulin Resistance. Lifestyle modifications recommended.</p>
                </div>
                <div class="term-item">
                    <p class="term">Score > 2.5</p>
                    <p class="definition">Significant Insulin Resistance. High risk for metabolic syndrome.</p>
                </div>
            </div>
        </div>

        <h2 id="section5">Functional vs. Laboratory Ranges</h2>
        <p>Standard laboratory "normal" ranges are based on a bell curve of the population that visits that lab. Given that over 80% of the US population is metabolically unhealthy, being "normal" is not the goal. <span class="highlight">Functional ranges</span> are based on the levels associated with the lowest risk of disease and the highest level of vitality.</p>

        <p>For example, most labs list the upper limit of Fasting Insulin as 24.9 ÂµIU/mL. However, research indicates that cardiovascular risk begins to climb significantly once fasting insulin exceeds 7.0 ÂµIU/mL. By the time a client reaches 24.9, they have likely been in a state of metabolic crisis for a decade.</p>

        <h2 id="section6">Integrating the STABLE Methodâ„¢</h2>
        <p>The <strong>Tactical Tracking (T)</strong> pillar is not just about collecting data; it's about using these three markers to drive the other pillars. If HOMA-IR is high, we prioritize <strong>Active Sensitization (A)</strong> to clear glucose via non-insulin dependent pathways. If A1c is high but insulin is low, we investigate <strong>Biological Synergy (B)</strong>, looking for potential beta-cell exhaustion or high cortisol levels driving the "Dawn Phenomenon."</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of metabolic markers</p>
            
            <div class="question-item">
                <p class="question-text">A client presents with a Fasting Glucose of 95 mg/dL and a Fasting Insulin of 20 ÂµIU/mL. What is their HOMA-IR, and what does it indicate?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Calculation: (95 Ã— 20) / 405 = 4.69. This score indicates <strong>Significant Insulin Resistance</strong>. Despite a "normal" fasting glucose, the client is in a high-risk metabolic state and requires immediate intervention.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">Why might a client with severe iron-deficiency anemia have an artificially high HbA1c?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    In iron-deficiency anemia, red blood cell turnover is reduced. This means individual RBCs circulate in the bloodstream longer than the typical 120 days, allowing them more time to become glycated, which inflates the HbA1c percentage regardless of actual average glucose.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>HbA1c is a lagging indicator</strong> that provides a 90-day average but can be skewed by red blood cell health and turnover rates.</li>
                <li><strong>Fasting Insulin is a leading indicator</strong>, often rising a decade before blood sugar levels become clinically "diabetic."</li>
                <li><strong>HOMA-IR is the most powerful tool</strong> for quantifying a client's specific level of insulin resistance (Optimal &lt; 1.5).</li>
                <li><strong>Functional ranges</strong> (Optimal) are significantly narrower than laboratory "normal" ranges; coaches must target these for true health.</li>
                <li><strong>Tactical Tracking</strong> requires correlating these lab values with real-world symptoms and CGM data to create a bio-individual plan.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <p>1. DeFronzo, R. A. et al. (2021). "The HOMA-IR: 35 Years Later." <em>Diabetes Care</em>.</p>
            <p>2. Johnson, R. K. et al. (2023). "Hyperinsulinemia as an Independent Predictor of Cardiovascular Disease: A Meta-Analysis." <em>Journal of Clinical Endocrinology & Metabolism</em>.</p>
            <p>3. Smith, G. J. et al. (2022). "Limitations of HbA1c in the Presence of Anemia and Hemoglobinopathies." <em>The Lancet Diabetes & Endocrinology</em>.</p>
            <p>4. American Diabetes Association (2024). "Standards of Care in Diabetesâ€”2024." <em>Diabetes Care</em>.</p>
            <p>5. Kraft, J. R. (2020). "Detection of Diabetes Mellitus in Situ with the Oral Glucose Tolerance Test: The Insulin Curve." <em>Laboratory Medicine</em>.</p>
            <p>6. Matthews, D. R. et al. (1985/Updated 2023). "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man." <em>Diabetologia</em>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>